Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment

• Váldodahkkit: Hung-Jun Lin (Dahkki), Tien-Li Liang (Dahkki), Yao-Yuan Chang (Dahkki), Der-Zen Liu (Dahkki), Jia-Yu Fan (Dahkki), Steve R. Roffler (Dahkki), Shyr-Yi Lin (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Pancreatic cancer is one of the most common causes of death in Taiwan. Previous studies have shown that more than 90% of pancreatic cancer cells presented epidermal growth factor receptor (EGFR) cell marker, and this marker is thought to be important as it is related to activation of cancer cell pro...